Manuel Cano1. 1. Department of Social Work, University of Texas at San Antonio, San Antonio, Texas, USA.
Abstract
BACKGROUND: The US drug overdose crisis has devastated communities across the nation, yet relatively little is known about recent impacts in diverse Hispanic populations. Purpose: This study explored demographic and drug patterns in overdose deaths among US Hispanics in 2017, as well as longer-term time trends in drug overdose mortality among Hispanics from 2000 to 2017. Methods: Death certificate data were obtained from the National Center for Health Statistics. Bivariate analyses examined demographic and drug characteristics of the 5,988 drug overdose deaths among Hispanics in 2017. Data from 2017 were also utilized to compute age-adjusted drug overdose mortality rates for Hispanics overall, for specific Hispanic heritage groups, and for Non-Hispanic Whites (as a frame of reference). Joinpoint Regression was used to characterize trends in drug overdose mortality among US Hispanic men and women between 2000 and 2017. Results: The majority of Hispanic drug overdose decedents in 2017 were male (76.1%) and US-born (70.0%). Synthetic opioids were involved in the highest proportion of deaths in all Hispanic heritages, except the Mexican heritage group, in which psychostimulants were most commonly involved. The 2017 age-adjusted drug overdose mortality rate for Hispanics overall was lower than the rate among Non-Hispanic Whites, yet the rate among Puerto Rican-heritage Hispanics (29.0, 95% CI 27.6-30.4) was 6% higher than among Non-Hispanic Whites (27.4, 95% CI 27.2-27.6). Conclusions: Results highlight substantial variation in Hispanic drug overdose mortality rates, indicating that national rates for Hispanics obscure higher-risk subgroups. The diverse demographic profiles of Hispanic drug overdose decedents underscore the need for culturally tailored interventions.
BACKGROUND: The US drug overdose crisis has devastated communities across the nation, yet relatively little is known about recent impacts in diverse Hispanic populations. Purpose: This study explored demographic and drug patterns in overdose deaths among US Hispanics in 2017, as well as longer-term time trends in drug overdosemortality among Hispanics from 2000 to 2017. Methods:Death certificate data were obtained from the National Center for Health Statistics. Bivariate analyses examined demographic and drug characteristics of the 5,988 drug overdose deaths among Hispanics in 2017. Data from 2017 were also utilized to compute age-adjusted drug overdosemortality rates for Hispanics overall, for specific Hispanic heritage groups, and for Non-Hispanic Whites (as a frame of reference). Joinpoint Regression was used to characterize trends in drug overdosemortality among US Hispanic men and women between 2000 and 2017. Results: The majority of Hispanic drug overdose decedents in 2017 were male (76.1%) and US-born (70.0%). Synthetic opioids were involved in the highest proportion of deaths in all Hispanic heritages, except the Mexican heritage group, in which psychostimulants were most commonly involved. The 2017 age-adjusted drug overdosemortality rate for Hispanics overall was lower than the rate among Non-Hispanic Whites, yet the rate among Puerto Rican-heritage Hispanics (29.0, 95% CI 27.6-30.4) was 6% higher than among Non-Hispanic Whites (27.4, 95% CI 27.2-27.6). Conclusions: Results highlight substantial variation in Hispanic drug overdosemortality rates, indicating that national rates for Hispanics obscure higher-risk subgroups. The diverse demographic profiles of Hispanic drug overdose decedents underscore the need for culturally tailored interventions.
Entities:
Keywords:
Hispanic; Latino; Overdose; cause of death; drug; mortality
Authors: Scott G Weiner; Aleta D Carroll; Nicholas M Brisbon; Claudia P Rodriguez; Charles Covahey; Erin J Stringfellow; Catherine DiGennaro; Mohammad S Jalali; Sarah E Wakeman Journal: J Subst Abuse Treat Date: 2022-04-30
Authors: Tarlise Townsend; David Kline; Ariadne Rivera-Aguirre; Amanda M Bunting; Pia M Mauro; Brandon D L Marshall; Silvia S Martins; Magdalena Cerdá Journal: Am J Epidemiol Date: 2022-03-24 Impact factor: 5.363
Authors: Manal Mansoor; Ryan McNeil; Taylor Fleming; Allison Barker; Sheila Vakharia; Kimberly Sue; Andrew Ivsins Journal: Int J Drug Policy Date: 2022-01-31
Authors: Samuel R Friedman; Leslie D Williams; Ashly E Jordan; Suzan Walters; David C Perlman; Pedro Mateu-Gelabert; Georgios K Nikolopoulos; Maria R Khan; Emmanuel Peprah; Jerel Ezell Journal: Int J Environ Res Public Health Date: 2022-06-17 Impact factor: 4.614